Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury

References

• Bhattamisra SK, Shak AT, Xi LW, et al. (2020). Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease. Int J Pharm 579:119148.
   PubMed Web of Science ®Google Scholar
• Boban PT, Nambisan B, Sudhakaran PR. (2009). Dietary mucilage promotes regression of atheromatous lesions in hypercholesterolemic rabbits. Phytother Res 23:725–30.
   PubMed Web of Science ®Google Scholar
• Cai Y, Zhang W, Chen Z, et al. (2016). Recent insights into the biological activities and drug delivery systems of tanshinones. Int J Nanomedicine 11:121–30.
   PubMed Web of Science ®Google Scholar
• Cherubini A, Ruggiero C, Polidori MC, Mecocci P. (2005). Potential markers of oxidative stress in stroke. Free Radic Biol Med 39:841–52.
   PubMed Web of Science ®Google Scholar
• Cho J, Kim YH, Kong JY, et al. (2002). Protection of cultured rat cortical neurons from excitotoxicity by asarone, a major essential oil component in the rhizomes of Acorus gramineus. Life Sci 71:591–9.
   PubMed Web of Science ®Google Scholar
• Cuartero MI, de la Parra J, García-Culebras A, et al. (2016). The kynurenine pathway in the acute and chronic phases of cerebral ischemia. Curr Pharm Des 22:1060–73.
   PubMed Web of Science ®Google Scholar
• Cui J, Chen X, Zhai X, et al. (2016). Inhalation of water electrolysis-derived hydrogen ameliorates cerebral ischemia–reperfusion injury in rats – a possible new hydrogen resource for clinical use. Neuroscience 335:232–41.
   PubMed Web of Science ®Google Scholar
• Dong T, Chen N, Ma X, et al. (2018). The protective roles of l-borneolum, d-borneolum and synthetic borneol in cerebral ischaemia via modulation of the neurovascular unit. Biomed Pharmacother 102:874–83.
   PubMed Web of Science ®Google Scholar
• Duan W, Wang L, Lv J, et al. (2019). Metabolomics study on the effects of salvianolic acid B and borneol for treating cerebral ischemia in rats by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry. Rejuvenation Res 22:313–24.
   PubMed Web of Science ®Google Scholar
• Fan X, Chai L, Zhang H, et al. (2015). Borneol depresses P-glycoprotein function by a NF-κB signaling mediated mechanism in a blood brain barrier in vitro model. Int J Mol Sci 16:27576–88.
   PubMed Web of Science ®Google Scholar
• Fan Y, Luo Q, Wei J, et al. (2018). Mechanism of salvianolic acid B neuroprotection against ischemia/reperfusion induced cerebral injury. Brain Res 1679:125–33.
   PubMed Web of Science ®Google Scholar
• Fazil M, Md S, Haque S, et al. (2012). Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci 47:6–15.
   PubMed Web of Science ®Google Scholar
• Gänger S, Schindowski K. (2018). Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa. Pharmaceutics 10:116.
   PubMed Web of Science ®Google Scholar
• Gao H. (2016). Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B 6:268–86.
   PubMed Web of Science ®Google Scholar
• Han JY, Fan JY, Horie Y, et al. (2008). Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther 117:280–95.
   PubMed Web of Science ®Google Scholar
• Illum L. (2002). Nasal drug delivery: new developments and strategies. Drug Discov Today 7:1184–9.
   PubMed Web of Science ®Google Scholar
• Khan AR, Liu M, Khan MW, Zhai G. (2017). Progress in brain targeting drug delivery system by nasal route. J Control Release 268:364–89.
   PubMed Web of Science ®Google Scholar
• Kumar A, Mittal R, Khanna HD, Basu S. (2008). Free radical injury and blood–brain barrier permeability in hypoxic-ischemic encephalopathy. Pediatrics 122:e722–e7.
   PubMed Web of Science ®Google Scholar
• Liu B-L, Shi M-X, Zhu Z-J, et al. (2016). Optimization of preparation of curcumin-catanionic nanoparticles lipid carriers by central composite design-response surface methodology. Chin Tradit Herb Drugs 47:3401.
   Google Scholar
• Liu CH, Wu CT, Fang JY. (2010b). Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery. Drug Dev Ind Pharm 36:751–61.
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang L, Lan X, et al. (2011). Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κappaB signaling pathway. Neuroscience 176:408–19.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang X, Wang L, et al. (2010a). The neuroprotective effects of tanshinone IIA are associated with induced nuclear translocation of TORC1 and upregulated expression of TORC1, pCREB and BDNF in the acute stage of ischemic stroke. Brain Res Bull 82:228–33.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang X, Zhang J, et al. (2014). Diosmin protects against cerebral ischemia/reperfusion injury through activating JAK2/STAT3 signal pathway in mice. Neuroscience 268:318–27.
   PubMed Web of Science ®Google Scholar
• Lochhead JJ, Thorne RG. (2012). Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 64:614–28.
   PubMed Web of Science ®Google Scholar
• Longa EZ, Weinstein PR, Carlson S, Cummins R. (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84–91.
   PubMed Web of Science ®Google Scholar
• Lu Y, Chen X, Du S, et al. (2010). The in situ and in vivo study on enhancing effect of borneol in nasal absorption of geniposide in rats. Arch Pharm Res 33:691–6.
   PubMed Web of Science ®Google Scholar
• Ohsawa I, Ishikawa M, Takahashi K, et al. (2007). Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13:688–94.
   PubMed Web of Science ®Google Scholar
• Padowski JM, Pollack GM. (2010). Examination of the ability of the nasal administration route to confer a brain exposure advantage for three chemical inhibitors of P-glycoprotein. J Pharm Sci 99:3226–33.
   PubMed Web of Science ®Google Scholar
• Pasha S, Gupta K. (2010). Various drug delivery approaches to the central nervous system. Expert Opin Drug Deliv 7:113–35.
   PubMed Web of Science ®Google Scholar
• Peluffo H, Unzueta U, Negro-Demontel ML, et al. (2015). BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS. Biotechnol Adv 33:277–87.
   PubMed Web of Science ®Google Scholar
• Ren J, Zou M, Gao P, et al. (2013). Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration. Eur J Pharm Biopharm 83:141–8.
   PubMed Web of Science ®Google Scholar
• Tang C, Xue H, Bai C, et al. (2010). The effects of tanshinone IIA on blood–brain barrier and brain edema after transient middle cerebral artery occlusion in rats. Phytomedicine 17:1145–9.
   PubMed Web of Science ®Google Scholar
• Tao HQ, Meng Q, Li MH, et al. (2013). HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia–reperfusion injury in rats. Naunyn Schmiedebergs Arch Pharmacol 386:61–70.
   PubMed Web of Science ®Google Scholar
• Turner RC, Dodson SC, Rosen CL, Huber JD. (2013). The science of cerebral ischemia and the quest for neuroprotection: navigating past failure to future success. J Neurosurg 118:1072–85.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao X, Du J, et al. (2019). Improved brain delivery of pueraria flavones via intranasal administration of borneol-modified solid lipid nanoparticles. Nanomedicine 14:2105–19.
   PubMed Web of Science ®Google Scholar
• Wu KJ, Hsieh MT, Wu CR, et al. (2012). Green tea extract ameliorates learning and memory deficits in ischemic rats via its active component polyphenol epigallocatechin-3-gallate by modulation of oxidative stress and neuroinflammation. Evid Based Complement Alternat Med 2012:163106.
   PubMed Web of Science ®Google Scholar
• Wu MY, Yiang GT, Liao WT, et al. (2018). Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem 46:1650–67.
   PubMed Web of Science ®Google Scholar
• Xu X, Chua CC, Gao J, et al. (2006). Humanin is a novel neuroprotective agent against stroke. Stroke 37:2613–9.
   PubMed Web of Science ®Google Scholar
• Yang X, Chen X, Lei T, et al. (2020). The construction of in vitro nasal cavity-mimic M-cell model, design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration. Acta Pharm Sin B 10:1094–105.
   PubMed Web of Science ®Google Scholar
• Yang Z, Weian C, Susu H, Hanmin W. (2016). Protective effects of mangiferin on cerebral ischemia–reperfusion injury and its mechanisms. Eur J Pharmacol 771:145–51.
   PubMed Web of Science ®Google Scholar
• Ye X, Peng X, Song Q, et al. (2021). Borneol-modified tanshinone IIA liposome improves cerebral ischemia reperfusion injury by suppressing NF-κB and ICAM-1 expression. Drug Dev Ind Pharm 47:609–17.
   PubMed Web of Science ®Google Scholar
• Yu B, Ruan M, Dong X, et al. (2013). The mechanism of the opening of the blood–brain barrier by borneol: a pharmacodynamics and pharmacokinetics combination study. J Ethnopharmacol 150:1096–108.
   PubMed Web of Science ®Google Scholar
• Yu L, Yang B, Wang J, et al. (2014). Time course change of COX2-PGI2/TXA2 following global cerebral ischemia reperfusion injury in rat hippocampus. Behav Brain Funct 10:42.
   PubMed Web of Science ®Google Scholar
• Yun X, Maximov VD, Yu J, et al. (2013). Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury. J Cereb Blood Flow Metab 33:583–92.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Q, Zha L, et al. (2004). Preparation, characterization and application of pyrene-loaded methoxy poly(ethylene glycol)–poly(lactic acid) copolymer nanoparticles. Colloid Polym Sci 282:1323–8.
   Web of Science ®Google Scholar
• Zou L, Wang D, Hu Y, et al. (2017). Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG–PAMAM nanoparticles. Oncotarget 8:60453–68.
   PubMedGoogle Scholar